Adjunct Instructor at Tsinghua Medical School @ (March 2016 - Present)
Chief Medical Officer @ (November 2021 - June 2026)
Adjunct Professor @ (December 2016 - December 2022)
Founder, Chairman and CEO @ DeltaMed Co. Ltd 德泰迈医药科技有限公司 (May 2018 - January 2022)
Partner @ Yuanming Capital (February 2015 - January 2022)
CEO and Founder @ Hangzhou Tigermed-IntelliPV (November 2013 - April 2018)
Chief Medical Officer @ (January 2015 - January 2017)
Senior Director at Global Safety @ (July 2008 - November 2012)
Medical Director at GPVE @ (July 2007 - July 2008)
Director of Global Pharmacovigilance @ (April 2006 - July 2007)
Safety Physician @ (May 2000 - June 2005)
Medical Safety Scientist @ (May 1998 - May 2000)
Howe 李浩 Education
The University of North Carolina at Chapel Hill
Post-doctoral Fellow (Molecular Biology and Biochemistry)
1991-1993
Peking Union Medical College
Master of Medicine (Pathology)
1986-1991
TongJi Medical College of HUST
MD (Clinical Medicine)
1981-1986
Howe 李浩 Skills
Argus Safety
Biopharmaceuticals
Biotechnology
CRO
Clinical Development
Clinical Research
Clinical Trials
Drug Development
Drug Safety
FDA
GCP
Life Sciences
Lifesciences
Medical Devices
Medical Writing
Oncology
Pharmaceutical Industry
Pharmaceutics
Pharmacovigilance
Regulatory Affairs
Regulatory Submissions
SOP
Howe 李浩 Summary
Howe 李浩, based in Shanghai, China, is currently a Acting CMO at Himalaya Therapeutics. Howe 李浩 brings experience from previous roles at 丽维泰生物医药(上海)有限公司 (LIVIUS Shanghai Pharmaceutical LTD), Tsinghua University, Pharmaron and Shanghai Jiao Tong University School of Medicine. Howe 李浩 holds a 1991 - 1993 Post-doctoral Fellow in Molecular Biology and Biochemistry @ The University of North Carolina at Chapel Hill. With a robust skill set that includes Argus Safety, Biopharmaceuticals, Biotechnology, CRO, Clinical Development and more. Howe 李浩 has 1 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Howe 李浩?
Find contact details for 700 million professionals.